J. J. Augustine and D. E. Hricik, Minimization of immunosuppression in kidney transplantation, Curr Opin Nephrol Hypertens, vol.16, p.535, 2007.

R. I. Lechler, O. A. Garden, and L. A. Turka, The complementary roles of deletion and regulation in transplantation tolerance, Nat Rev Immunol, vol.3, p.147, 2003.

R. A. Schroeder, C. E. Marroquin, and P. C. Kuo, Tolerance and the "Holy Grail" of transplantation, J Surg Res, vol.111, p.109, 2003.

H. Yang, Maintenance immunosuppression regimens: conversion, minimization, withdrawal, and avoidance, Am J Kidney Dis, vol.47, p.37, 2006.

M. C. Londono, M. C. Lopez, and A. Sanchez-fueyo, Minimization of immunosuppression in adult liver transplantation: new strategies and tools, Curr Opin Organ Transplant, vol.15, p.685, 2010.

R. Shapiro, J. B. Young, E. L. Milford, J. F. Trotter, R. T. Bustami et al., Immunosuppression: evolution in practice and trends, Am J Transplant, vol.5, p.874, 1993.

Y. Vanrenterghem, J. P. Van-hooff, and J. P. Squifflet, Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial, Am J Transplant, vol.5, p.87, 2005.

H. U. Meier-kriesche, J. D. Schold, T. R. Srinivas, and B. Kaplan, Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era, Am J Transplant, vol.4, p.378, 2004.

A. D. Kirk, A. Guasch, and H. Xu, Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors, Am J Transplant, vol.14, p.1142, 2014.

V. H. Karam, I. Gasquet, and V. Delvart, Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation, Transplantation, vol.76, p.1699, 2003.

H. H. Hirsch, W. Knowles, and M. Dickenmann, Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients, N Engl J Med, vol.347, p.488, 2002.

R. Cortesini and N. Suciu-foca, The concept of "partial" clinical tolerance, Transpl Immunol, vol.13, p.101, 2004.

A. D. Kirk, Less is more: maintenance minimization as a step toward tolerance, Am J Transplant, vol.3, p.643, 2003.

H. Ekberg, C. Bernasconi, and H. Tedesco-silva, Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation, Am J Transplant, vol.9, p.1876, 2009.

M. H. Sayegh, Looking into the crystal ball: kidney transplantation in 2025, Nat Clin Pract Nephrol, vol.5, p.117, 2009.

R. Calne, P. Friend, and S. Moffatt, Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients, Lancet, vol.351, p.1701, 1998.

R. Y. Calne, Prope tolerance-the future of organ transplantation from the laboratory to the clinic, Int Immunopharmacol, vol.5, p.163, 2005.

A. P. Monaco, The beginning of clinical tolerance in solid organ allografts, Exp Clin Transplant, vol.2, p.153, 2004.

F. Vincenti, Immunosuppression minimization: current and future trends in transplant immunosuppression, J Am Soc Nephrol, vol.14, 1940.

F. Vincenti, Is complete avoidance of calcineurin inhibitors or steroids now possible? Importance of patient selection and choice of regimen, Transplant Proc, vol.33, p.11, 2001.

G. M. Danovitch, Immunosuppressive medications for renal transplantation: a multiple choice question, Kidney Int, vol.59, p.388, 2001.

A. O. Gaber, M. R. First, and R. J. Tesi, Results of the doubleblind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation, Transplantation, vol.66, p.29, 1998.

F. Vincenti, The role of newer monoclonal antibodies in renal transplantation, Transplant Proc, vol.33, p.1000, 2001.

F. Vincenti, What's in the pipeline? New immunosuppressive drugs in transplantation, Am J Transplant, vol.2, p.898, 2002.

K. E. Lunsford, A. S. Barbas, and T. V. Brennan, Recent advances in immunosuppressive therapy for prevention of renal allograft rejection, Curr Opin Organ Transplant, vol.16, p.390, 2011.

N. Pilat, C. Schwarz, and T. Wekerle, Modulating T-cell costimulation as new immunosuppressive concept in organ transplantation, Curr Opin Organ Transplant, vol.17, p.368, 2012.

A. J. Page, M. L. Ford, and A. D. Kirk, Memory T-cell-specific therapeutics in organ transplantation, Curr Opin Organ Transplant, vol.14, p.643, 2009.

K. J. Wood, A. Bushell, and J. Hester, Regulatory immune cells in transplantation, Nat Rev Immunol, vol.12, p.417, 2012.

S. D. Marks, New immunosuppressants in pediatric solid organ transplantation, Curr Opin Organ Transplant, vol.17, p.503, 2012.

A. Webber, R. Hirose, and F. Vincenti, Novel strategies in immunosuppression: issues in perspective, Transplantation, vol.91, p.1057, 2011.

R. E. Billingham, L. Brent, and P. B. Medawar, Actively acquired tolerance of foreign cells, Nature, vol.172, p.603, 1953.

J. Ashton-chess, S. Brouard, and J. P. Soulillou, Is clinical tolerance realistic in the next decade?, Transpl Int, vol.19, p.539, 2006.

T. Fehr and M. Sykes, Tolerance induction in clinical transplantation, Transpl Immunol, vol.13, p.117, 2004.

R. Girlanda and A. D. Kirk, Frontiers in nephrology: immune tolerance to allografts in humans, J Am Soc Nephrol, vol.18, p.2242, 2007.

E. K. Page, W. A. Dar, and S. J. Knechtle, Tolerogenic therapies in transplantation, Front Immunol, vol.3, 0198.

A. B. Cosimi, R. C. Burton, and R. B. Colvin, Treatment of acute renal allograft rejection with OKT3 monoclonal antibody, Transplantation, vol.32, p.535, 1981.

N. Poirier, A. M. Azimzadeh, and T. Zhang, Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation, Sci Transl Med, vol.2, pp.17-27, 2010.

F. Vincenti, B. Nashan, and S. Light, Daclizumab: outcome of phase III trials and mechanism of action. Double Therapy and the Triple Therapy Study Groups, Transplant Proc, vol.30, p.2155, 1998.

F. Vincenti, C. Larsen, and A. Durrbach, Costimulation blockade with belatacept in renal transplantation, N Engl J Med, vol.353, p.770, 2005.

T. Kawai, A. B. Cosimi, and T. R. Spitzer, HLA-mismatched renal transplantation without maintenance immunosuppression, N Engl J Med, vol.358, p.353, 2008.

J. D. Scandling, S. Busque, J. , and S. , Tolerance and chimerism after renal and hematopoietic-cell transplantation, N Engl J Med, vol.358, p.362, 2008.

Y. Sharabi and D. H. Sachs, Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen, J Exp Med, vol.169, p.493, 1989.

W. J. Burlingham, A. P. Grailer, J. H. Fechner, and . Jr, Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient, Transplantation, vol.59, p.1147, 1995.

C. I. Kingsley, S. N. Nadig, and K. J. Wood, Transplantation tolerance: lessons from experimental rodent models, Transpl Int, vol.20, p.828, 2007.

N. J. Monk, R. E. Hargreaves, E. Simpson, J. P. Dyson, and S. Jurcevic, Transplant tolerance: models, concepts and facts, J Mol Med (Berl), vol.84, p.295, 2006.

M. M. Hamawy and S. J. Knechtle, Strategies for tolerance induction in nonhuman primates, Curr Opin Immunol, vol.10, p.513, 1998.

T. Kawai, A. B. Cosimi, and D. H. Sachs, Preclinical and clinical studies on the induction of renal allograft tolerance through transient mixed chimerism, Curr Opin Organ Transplant, vol.16, p.366, 2011.

J. D. Eason, A. J. Cohen, S. Nair, T. Alcantera, and G. E. Loss, Tolerance: is it worth the risk?, Transplantation, vol.79, p.1157, 2005.

A. D. Salama, G. Remuzzi, W. E. Harmon, and M. H. Sayegh, Challenges to achieving clinical transplantation tolerance, J Clin Invest, vol.108, p.943, 2001.

A. D. Kirk, Ethics in the quest for transplant tolerance, Transplantation, vol.77, p.947, 2004.

A. Ojo, R. A. Wolfe, and L. Y. Agodoa, Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System, Transplantation, vol.66, p.1651, 1998.

H. Auchincloss, In search of the elusive Holy Grail: the mechanisms and prospects for achieving clinical transplantation tolerance, Am J Transplant, vol.1, p.6, 2001.

M. T. Millan, J. A. Shizuru, and P. Hoffmann, Mixed chimerism and immunosuppressive drug withdrawal after HLAmismatched kidney and hematopoietic progenitor transplantation, Transplantation, vol.73, p.1386, 2002.

K. Budde, M. Matz, M. Durr, and P. Glander, Biomarkers of overimmunosuppression, Clin Pharmacol Ther, vol.90, p.316, 2011.

M. H. Sayegh and G. Remuzzi, Clinical update: immunosuppression minimisation, Lancet, vol.369, p.1676, 2007.
DOI : 10.1016/s0140-6736(07)60762-4

J. Ashton-chess, M. Giral, J. P. Soulillou, and S. Brouard, Can immune monitoring help to minimize immunosuppression in kidney transplantation?, Transpl Int, vol.22, p.110, 2009.

J. M. Tredger, N. W. Brown, and A. Dhawan, Immunosuppression in pediatric solid organ transplantation: opportunities, risks, and management, Pediatr Transplant, vol.10, p.879, 2006.

H. Abboudi and I. A. Macphee, Individualized immunosuppression in transplant patients: potential role of pharmacogenetics, Pharmgenomics Pers Med, vol.5, p.63, 2012.

J. B. Matthews, E. Ramos, and J. A. Bluestone, Clinical trials of transplant tolerance: slow but steady progress, Am J Transplant, vol.3, p.794, 2003.

S. P. Cobbold and X. C. Li, Translating Tolerogenic Therapies to the Clinic -Where Do We Stand and What are the Barriers?, Front Immunol, vol.3, p.317, 2012.

F. Issa and K. J. Wood, Translating tolerogenic therapies to the clinic -where do we stand?, Front Immunol, vol.3, p.254, 2012.

A. B. Adams, M. A. Williams, and T. R. Jones, Heterologous immunity provides a potent barrier to transplantation tolerance, J Clin Invest, vol.111, p.1887, 2003.

P. S. Heeger, Frontiers in nephrology: tolerance, J Am Soc Nephrol, vol.18, p.2240, 2007.

E. M. Salisbury, D. S. Game, and R. I. Lechler, Transplantation tolerance, Pediatr Nephrol, vol.29, p.2263, 2014.

A. Sanchez-fueyo and T. B. Strom, Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs, Gastroenterology, vol.140, p.51, 2011.

J. D. Scandling, S. Busque, J. A. Shizuru, E. G. Engleman, and S. Strober, Induced immune tolerance for kidney transplantation, N Engl J Med, vol.365, p.1359, 2011.

D. Chandrasekharan, F. Issa, and K. J. Wood, Achieving operational tolerance in transplantation: how can lessons from the clinic inform research directions?, Transpl Int, vol.26, p.576, 2013.

N. Najafian, M. J. Albin, and K. A. Newell, How can we measure immunologic tolerance in humans?, J Am Soc Nephrol, vol.17, p.2652, 2006.

K. A. Newell and C. P. Larsen, Tolerance assays: measuring the unknown, Transplantation, vol.81, p.1503, 2006.

L. A. Turka and R. I. Lechler, Towards the identification of biomarkers of transplantation tolerance, Nat Rev Immunol, vol.9, p.521, 2009.

P. A. Lachenbruch, A. S. Rosenberg, E. Bonvini, M. W. Cavaille-coll, and R. B. Colvin, Biomarkers and surrogate endpoints in renal transplantation: present status and considerations for clinical trial design, Am J Transplant, vol.4, p.451, 2004.

B. Sis, M. Mengel, and M. Haas, 09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups, Am J Transplant, vol.10, p.464, 2010.

R. Bellomo, J. A. Kellum, and C. Ronco, Defining acute renal failure: physiological principles, Intensive Care Med, vol.30, p.33, 2004.

M. C. Londono, R. Danger, M. Giral, J. P. Soulillou, A. Sanchezfueyo et al., A need for biomarkers of operational tolerance in liver and kidney transplantation, Am J Transplant, vol.12, p.1370, 2012.

S. Heidt and K. J. Wood, Biomarkers of operational tolerance in solid organ transplantation, Expert Opin Med Diagn, vol.6, p.281, 2012.

M. Naesens and M. M. Sarwal, Molecular diagnostics in transplantation, Nat Rev Nephrol, vol.6, p.614, 2010.

S. Roedder, M. Vitalone, P. Khatri, and M. M. Sarwal, Biomarkers in solid organ transplantation: establishing personalized transplantation medicine, Genome Med, vol.3, p.37, 2011.

B. Sawitzki, A. Pascher, N. Babel, P. Reinke, and H. D. Volk, Can we use biomarkers and functional assays to implement personalized therapies in transplantation?, Transplantation, vol.87, p.1595, 2009.

P. Nickerson, Post-transplant monitoring of renal allografts: are we there yet?, Curr Opin Immunol, vol.21, p.563, 2009.

N. Townamchai, K. Safa, and A. Chandraker, Immunologic monitoring in kidney transplant recipients, Kidney Res Clin Pract, vol.32, p.52, 2013.

S. Brouard, J. Shton-chess, and J. P. Soulillou, Surrogate markers for the prediction of long-term outcome in transplantation: Nantes Actualite Transplantation (NAT) 2007 meeting report, Hum Immunol, vol.69, issue.2, 2008.

P. Chowdhury and M. P. Hernandez-fuentes, Non-invasive biomarkers to guide management following renal transplantation: the need for a multiplatform approach, Curr Opin Organ Transplant, vol.18, p.1, 2013.

G. Orlando, P. Hematti, and R. J. Stratta, Clinical operational tolerance after renal transplantation: current status and future challenges, Ann Surg, vol.252, p.915, 2010.

J. Ashton-chess, M. Giral, S. Brouard, and J. P. Soulillou, Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation, Transplantation, vol.84, p.1215, 2007.

K. A. Newell, Clinical transplantation tolerance. Semin Immunopathol, vol.33, p.91, 2011.

E. Dugast, M. Chesneau, J. P. Soulillou, and S. Brouard, Biomarkers and possible mechanisms of operational tolerance in kidney transplant patients, Immunol Rev, vol.258, p.208, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02163167

B. Sawitzki, P. Reinke, A. Pascher, and H. D. Volk, State of the art on the research for biomarkers allowing individual, tailormade minimization of immunosuppression, Curr Opin Organ Transplant, vol.15, p.691, 2010.

Y. Aiba, T. Yamazaki, and T. Okada, BANK negatively regulates Akt activation and subsequent B cell responses, Immunity, vol.24, p.259, 2006.

S. Brouard, A. Pallier, and K. Renaudin, The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases, Am J Transplant, vol.12, p.3296, 2012.

G. Roussey-kesler, M. Giral, and A. Moreau, Clinical operational tolerance after kidney transplantation, Am J Transplant, vol.6, p.736, 2006.

J. P. Soulillou, M. Giral, and S. Brouard, Operational tolerance in kidney transplantation-improved terminology may enable more precise investigation, Transplantation, vol.96, p.36, 2013.

K. M. Zoller, S. I. Cho, J. J. Cohen, and J. T. Harrington, Cessation of immunosuppressive therapy after successful transplantation: a national survey, Kidney Int, vol.18, p.110, 1980.

T. E. Starzl, N. Murase, and A. J. Demetris, Lessons of organinduced tolerance learned from historical clinical experience, Transplantation, vol.77, p.926, 2004.

R. Weil, . Iii, T. E. Starzl, K. A. Porter, M. Kershaw et al., Renal isotransplantation without immunosuppression, Ann Surg, vol.192, p.108, 1980.

J. S. Maltzman and G. A. Koretzky, Azathioprine: old drug, new actions, J Clin Invest, vol.111, p.1122, 2003.
DOI : 10.1172/jci18384

URL : http://www.jci.org/articles/view/18384/files/pdf

J. E. Murray, J. P. Merrill, J. H. Harrison, R. E. Wilson, and G. J. Dammin, Prolonged survival of human-kidney homografts by immunosuppressive drug therapy, N Engl J Med, vol.268, p.1315, 1963.

L. Bererhi, N. Pallet, and J. Zuber, Clinical and immunological features of very long-term survivors with a single renal transplant, Transpl Int, vol.25, p.545, 2012.

W. E. Braun, D. A. Protiva, and J. D. Schold, Decreased total CD19 (+) B lymphocytes and the occurrence of monoclonal proteins are frequent in ultra-long (30 to 44-year) renal transplant recipients: implications for allograft and patient survival, Transplant Proc, vol.45, p.1466, 2013.

F. Moreso, I. B. Torres, and M. Martinez-gallo, Gene expression signature of tolerance and lymphocyte subsets in stable renal transplants: results of a cross-sectional study, Transpl Immunol, vol.31, p.11, 2014.

R. Y. Calne and A. J. Wood, Cyclosporin in cadaveric renal transplantation: 3-year follow-up of a European multicentre trial, Lancet, vol.2, p.549, 1985.

Z. M. El-zoghby, M. D. Stegall, and D. J. Lager, Identifying specific causes of kidney allograft loss, Am J Transplant, vol.9, p.527, 2009.

S. Gourishankar, R. Leduc, and J. Connett, Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study, Am J Transplant, vol.10, p.324, 2010.

A. J. Matas, Chronic progressive calcineurin nephrotoxicity: an overstated concept, Am J Transplant, vol.11, p.687, 2011.
DOI : 10.1111/j.1600-6143.2011.03505.x

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-6143.2011.03505.x

J. R. Pinto, R. Torres, E. M. Franco, and A. , Sirolimus monotherapy as maintenance immunosuppression: a multicenter experience, Transpl Int, vol.23, p.307, 2010.
DOI : 10.1111/j.1432-2277.2009.00983.x

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1432-2277.2009.00983.x

R. Snanoudj, V. Royal, and C. Elie, Specificity of histological markers of long-term CNI nephrotoxicity in kidneytransplant recipients under low-dose cyclosporine therapy, Am J Transplant, vol.11, p.2635, 2011.

T. E. Starzl, T. L. Marchioro, and W. R. Waddell, The reversal of rejection in human renal homografts with subsequent development of homograft tolerance, Surg Gynecol Obstet, vol.117, p.385, 1963.

T. E. Starzl and R. M. Zinkernagel, Transplantation tolerance from a historical perspective, Nat Rev Immunol, vol.1, p.233, 2001.

T. E. Starzl, The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967), J Am Coll Surg, vol.195, p.587, 2002.

L. L. Christensen, N. Grunnet, N. Rudiger, B. Moller, and S. A. Birkeland, Indications of immunological tolerance in kidney transplantation, Tissue Antigens, vol.51, p.637, 1998.

T. Fischer, H. Schobel, and M. Barenbrock, Specific immune tolerance during pregnancy after renal transplantation, Eur J Obstet Gynecol Reprod Biol, vol.70, p.217, 1996.
DOI : 10.1016/s0301-2115(95)02581-2

L. D. Haynes, E. Jankowska-gan, and A. Sheka, Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients, Am J Transplant, vol.12, p.640, 2012.

D. T. Uehling, J. L. Hussey, A. B. Weinstein, R. Wank, and F. H. Bach, Cessation of immunosuppression after renal transplantation, Surgery, vol.79, p.278, 1976.

C. Ballet, G. Roussey-kesler, and J. T. Aubin, Humoral and cellular responses to influenza vaccination in human recipients naturally tolerant to a kidney allograft, Am J Transplant, vol.6, p.2796, 2006.

A. M. Vanbuskirk, W. J. Burlingham, and E. Jankowska-gan, Human allograft acceptance is associated with immune regulation, J Clin Invest, vol.106, p.145, 2000.

D. Baeten, S. Louis, and C. Braud, Phenotypically and functionally distinct CD8+ lymphocyte populations in longterm drug-free tolerance and chronic rejection in human kidney graft recipients, J Am Soc Nephrol, vol.17, p.294, 2006.

L. E. Becker, B. F. De-oliveira, and H. Conrad, Cellular infiltrates and NFkappaB subunit c-Rel signaling in kidney allografts of patients with clinical operational tolerance, Transplantation, vol.94, p.729, 2012.

C. Braud, D. Baeten, and M. Giral, Immunosuppressive drug-free operational immune tolerance in human kidney transplant recipients: Part I. Blood gene expression statistical analysis, J Cell Biochem, vol.103, p.1681, 2008.

C. Braudeau, M. Racape, and M. Giral, Variation in numbers of CD4+ CD25 high FOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome, Transpl Int, vol.20, p.845, 2007.

C. Braudeau, J. Shton-chess, and M. Giral, Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients, Transplantation, vol.86, p.130, 2008.

S. Brouard, A. Dupont, and M. Giral, Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation, Am J Transplant, vol.5, p.330, 2005.

S. Brouard, B. A. Le, and A. Dufay, Identification of a gene expression profile associated with operational tolerance among a selected group of stable kidney transplant patients, Transpl Int, vol.24, p.536, 2011.

R. Danger, E. Thervet, and M. L. Grisoni, PARVG gene polymorphism and operational renal allograft tolerance, Transplant Proc, vol.44, p.2845, 2012.

R. Danger, A. Pallier, and M. Giral, Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant, J Am Soc Nephrol, vol.23, p.597, 2012.

S. Louis, C. Braudeau, and M. Giral, Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance, Transplantation, vol.81, p.398, 2006.

J. J. Lozano, A. Pallier, and M. Martinez-llordella, Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients, Am J Transplant, vol.11, 1916.

P. M. Moraes-vieira, H. M. Silva, and M. C. Takenaka, Differential monocyte STAT6 activation and CD4(+)CD25(+) Foxp3(+) T cells in kidney operational tolerance transplanted individuals, Hum Immunol, vol.71, p.442, 2010.

P. M. Moraes-vieira, M. C. Takenaka, and H. M. Silva, GATA3 and a dominant regulatory gene expression profile discriminate operational tolerance in human transplantation, Clin Immunol, vol.142, p.117, 2012.

K. A. Newell, A. Asare, and A. D. Kirk, Identification of a B cell signature associated with renal transplant tolerance in humans, J Clin Invest, vol.120, p.1836, 2010.

A. Pallier, S. Hillion, and R. Danger, Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype, Kidney Int, vol.78, p.503, 2010.

P. Sagoo, E. Perucha, and B. Sawitzki, Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans, J Clin Invest, vol.120, p.1848, 2010.

N. Najafian, A. D. Salama, E. V. Fedoseyeva, G. Benichou, and M. H. Sayegh, Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients, J Am Soc Nephrol, vol.13, p.252, 2002.

E. D. Poggio, M. Clemente, D. E. Hricik, and P. S. Heeger, Panel of reactive T cells as a measurement of primed cellular alloimmunity in kidney transplant candidates, J Am Soc Nephrol, vol.17, p.564, 2006.

D. Perkins, M. Verma, and K. J. Park, Advances of genomic science and systems biology in renal transplantation: a review, Semin Immunopathol, vol.33, p.211, 2011.

S. C. Hoffmann, J. P. Pearl, P. J. Blair, and A. D. Kirk, Immune profiling: molecular monitoring in renal transplantation, Front Biosci, vol.8, p.444, 2003.

T. K. Sigdel, X. Gao, and M. M. Sarwal, Protein and peptide biomarkers in organ transplantation, Biomark Med, vol.6, p.259, 2012.

F. Braza, J. P. Soulillou, and S. Brouard, Reconsidering the biodetection of tolerance in renal transplantation, Chimerism, vol.4, p.15, 2013.

R. Danger, M. Racape, J. P. Soulillou, and S. Brouard, What can we learn from the transcriptional characterization of spontaneously tolerant transplant recipients?, Curr Opin Organ Transplant, vol.15, p.435, 2010.

F. Braza, J. P. Soulillou, and S. Brouard, Gene expression signature in transplantation tolerance, Clin Chim Acta, vol.413, p.1414, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-02167912

M. P. Hernandez-fuentes and R. I. Lechler, A 'biomarker signature' for tolerance in transplantation, Nat Rev Nephrol, vol.6, p.606, 2010.

A. J. Demetris, J. G. Lunz, . Iii, P. Randhawa, T. Wu et al., Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective, Transpl Int, vol.22, p.120, 2009.

R. Hilton and M. Hernandez-fuentes, Biomarkers of tolerance: hope or hype?, Trends Transplant, vol.4, p.68, 2010.

M. Ilie, V. Hofman, and E. Long-mira, Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease, PLoS ONE, vol.9, p.111597, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01687052

S. A. Villeda, K. E. Plambeck, and J. Middeldorp, Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice, Nat Med, vol.20, p.659, 2014.

J. Ashton-chess, E. Dugast, and R. B. Colvin, Regulatory, effector, and cytotoxic T cell profiles in long-term kidney transplant patients, J Am Soc Nephrol, vol.20, p.1113, 2009.

V. R. Mas, L. A. Mas, and K. J. Archer, Evaluation of gene panel mRNAs in urine samples of kidney transplant recipients as a non-invasive tool of graft function, Mol Med, vol.13, p.315, 2007.

T. Muthukumar, D. Dadhania, and R. Ding, Messenger RNA for FOXP3 in the urine of renal-allograft recipients, N Engl J Med, vol.353, p.2342, 2005.

E. Perucha, I. Rebollo-mesa, P. Sagoo, and M. P. Hernandez-fuentes, Biomarkers of tolerance: searching for the hidden phenotype, Kidney Int Suppl, p.40, 2011.

S. Brouard, E. Mansfield, and C. Braud, Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance, Proc Natl Acad Sci, vol.104, p.15448, 2007.

K. A. Newell, D. Phippard, and L. A. Turka, Regulatory cells and cell signatures in clinical transplantation tolerance, Curr Opin Immunol, vol.23, p.655, 2011.

D. Baron, G. Ramstein, and M. Chesneau, A common gene signature across multiple studies identifies biomarkers and functional regulation in tolerance to renal allograft, Kidney Int, 2015.

M. Chesneau, A. Pallier, and F. Braza, Unique B cell differentiation profile in tolerant kidney transplant patients, Am J Transplant, vol.14, p.144, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00974748

J. D. Bouaziz, K. Yanaba, and T. F. Tedder, Regulatory B cells as inhibitors of immune responses and inflammation, Immunol Rev, vol.224, p.201, 2008.

M. Girndt, M. Sester, U. Sester, H. Kaul, and H. Kohler, Molecular aspects of T-and B-cell function in uremia, Kidney Int Suppl, vol.78, p.206, 2001.

M. V. Pahl, S. Gollapudi, L. Sepassi, P. Gollapudi, R. Elahimehr et al., Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression, Nephrol Dial Transplant, vol.25, p.205, 2010.

M. Smogorzewski and S. G. Massry, Defects in B-cell function and metabolism in uremia: role of parathyroid hormone, Kidney Int Suppl, vol.78, p.186, 2001.

F. Porcheray, W. Wong, and S. L. Saidman, B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans, Am J Transplant, vol.9, p.2126, 2009.

S. Heidt, J. Hester, S. Shankar, P. J. Friend, and K. J. Wood, B cell repopulation after alemtuzumab induction-transient increase in transitional B cells and long-term dominance of naive B cells, Am J Transplant, vol.12, p.1784, 2012.

R. R. Redfield, . Iii, E. Rodriguez, and R. Parsons, Essential role for B cells in transplantation tolerance, Curr Opin Immunol, vol.23, p.685, 2011.

R. M. Jindal, J. T. Joseph, M. C. Morris, R. N. Santella, and L. S. Baines, Noncompliance after kidney transplantation: a systematic review, Transplant Proc, vol.35, p.2868, 2003.

H. M. Silva, M. C. Takenaka, and P. M. Moraes-vieira, Preserving the B-cell compartment favors operational tolerance in human renal transplantation, Mol Med, vol.18, p.733, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01959589

V. Coelho, D. Saitovitch, J. Kalil, and H. M. Silva, Rethinking the multiple roles of B cells in organ transplantation, Curr Opin Organ Transplant, vol.18, p.13, 2013.

M. R. Clatworthy, C. J. Watson, and G. Plotnek, B-cell-depleting induction therapy and acute cellular rejection, N Engl J Med, vol.360, p.2683, 2009.

L. Texier, L. , T. P. Lavault, and A. , Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile, Am J Transplant, vol.11, p.429, 2011.

I. F. Ashoor and N. Najafian, Rejection and regulation: a tight balance, Curr Opin Organ Transplant, vol.17, p.1, 2012.

C. Mauri and P. A. Blair, Regulatory B cells in autoimmunity: developments and controversies, Nat Rev Rheumatol, vol.6, p.636, 2010.

A. B. Adams and K. A. Newell, B cells in clinical transplantation tolerance, Semin Immunol, vol.24, p.92, 2012.

M. Chesneau, L. Michel, N. Degauque, and S. Brouard, Regulatory B cells and tolerance in transplantation: from animal models to human, Front Immunol, vol.4, p.497, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02165775

J. Stolp, L. A. Turka, and K. J. Wood, B cells with immune-regulating function in transplantation, Nat Rev Nephrol, vol.10, p.389, 2014.

V. Zarkhin, G. Chalasani, and M. M. Sarwal, The yin and yang of B cells in graft rejection and tolerance, Transplant Rev (Orlando), vol.24, p.67, 2010.

A. Mizoguchi and A. K. Bhan, A case for regulatory B cells, J Immunol, vol.176, p.705, 2006.

V. Lampropoulou, E. Calderon-gomez, and T. Roch, Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity, Immunol Rev, vol.233, p.146, 2010.

K. Yanaba, J. D. Bouaziz, K. M. Haas, J. C. Poe, M. Fujimoto et al., A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses, Immunity, vol.28, p.639, 2008.

K. Yanaba, J. D. Bouaziz, T. Matsushita, T. Tsubata, and T. F. Tedder, The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals, J Immunol, vol.182, p.7459, 2009.

M. Hagn and B. Jahrsdorfer, Why do human B cells secrete granzyme B? Insights into a novel B-cell differentiation pathway, Oncoimmunology, vol.1, p.1368, 2012.

M. Chesneau, L. Michel, and A. Chenouard, Tolerant kidney transplant patients display B cells with a CD5+CD27+CD138+ phenotype that express Granzyme B and show regulatory properties, J Am Soc Nephrol, 2015.

M. Perez-andres, B. Paiva, and W. G. Nieto, Human peripheral blood B-cell compartments: a crossroad in B-cell traffic, Cytometry B Clin Cytom, vol.78, issue.1, p.47, 2010.

A. Nouel, I. Segalen, and C. Jamin, B cells display an abnormal distribution and an impaired suppressive function in patients with chronic antibody-mediated rejection, Kidney Int, vol.85, p.590, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00955526

A. Cherukuri, D. M. Rothstein, and B. Clark, Immunologic human renal allograft injury associates with an altered IL-10/TNF-alpha expression ratio in regulatory B cells, J Am Soc Nephrol, vol.25, p.1575, 2014.

F. Braza, E. Dugast, and I. Panov, Central role of CD45RA À Foxp3 hi memory Tregs in clinical kidney transplantation tolerance, J Am Soc Nephrol, 2015.

A. Parker, K. Bowles, and J. A. Bradley, Management of posttransplant lymphoproliferative disorder in adult solid organ transplant recipients -BCSH and BTS Guidelines, Br J Haematol, vol.149, p.693, 2010.

S. M. Wahl and D. L. Rosenstreich, Role of B lymphocytes in cellmediated immunity. I. Requirement for T cells or T-cell products for antigen-induced B-cell activation, J Exp Med, vol.144, p.1175, 1976.

S. Brouard, M. Giral, J. P. Soulillou, and J. Shton-chess, Elaboration of gene expression-based clinical decision aids for kidney transplantation: where do we stand?, Transplantation, vol.91, p.691, 2011.

G. V. Mazariegos, Immunosuppression withdrawal after liver transplantation: what are the next steps?, Transplantation, vol.91, p.697, 2011.

G. Orlando, S. Soker, and K. Wood, Operational tolerance after liver transplantation, J Hepatol, vol.50, p.1247, 2009.

V. Benseler, G. W. Mccaughan, H. J. Schlitt, G. A. Bishop, D. G. Bowen et al., The liver: a special case in transplantation tolerance, Semin Liver Dis, vol.27, p.194, 2007.

I. N. Crispe, M. Giannandrea, I. Klein, B. John, B. Sampson et al., Cellular and molecular mechanisms of liver tolerance, Immunol Rev, vol.213, p.101, 2006.

U. Steger, C. Denecke, B. Sawitzki, M. Karim, N. D. Jones et al., Exhaustive differentiation of alloreactive CD8+ T cells: critical for determination of graft acceptance or rejection, Transplantation, vol.85, p.1339, 2008.

A. J. Demetris, K. Ruppert, and I. Dvorchik, Real-time monitoring of acute liver-allograft rejection using the Banff schema, Transplantation, vol.74, p.1290, 2002.

R. H. Wiesner, A. J. Demetris, and S. H. Belle, Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome, Hepatology, vol.28, p.638, 1998.

G. V. Mazariegos, J. Reyes, and I. R. Marino, Weaning of immunosuppression in liver transplant recipients, Transplantation, vol.63, p.243, 1997.

H. C. Ramos, J. Reyes, and K. Bu-elmagd, Weaning of immunosuppression in long-term liver transplant recipients, Transplantation, vol.59, p.212, 1995.

A. J. Demetris, N. Murase, and K. Nakamura, Immunopathology of antibodies as effectors of orthotopic liver allograft rejection, Semin Liver Dis, vol.12, p.51, 1992.

A. Demetris, D. Adams, and C. Bellamy, Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel, Hepatology, vol.31, p.792, 2000.

A. Sanchez-fueyo, Hot-topic debate on tolerance: immunosuppression withdrawal, Liver Transpl, vol.17, issue.3, p.69, 2011.

O. Viklicky, E. Krystufkova, and I. Brabcova, B-cell-related biomarkers of tolerance are up-regulated in rejection-free kidney transplant recipients, Transplantation, vol.95, p.148, 2013.

M. C. Salinas-carmona, L. I. Perez, K. Galan, and A. V. Vazquez, Immunosuppressive drugs have different effect on B lymphocyte subsets and IgM antibody production in immunized BALB/c mice, Autoimmunity, vol.42, p.537, 2009.

J. Kwun, P. Bulut, and E. Kim, The role of B cells in solid organ transplantation, Semin Immunol, vol.24, p.96, 2012.

D. Poppe, I. Tiede, and G. Fritz, Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins, J Immunol, vol.176, p.640, 2006.

A. L. Taylor, C. J. Watson, and J. A. Bradley, Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy, Crit Rev Oncol Hematol, vol.56, p.23, 2005.

I. Tiede, G. Fritz, and S. Strand, CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes, J Clin Invest, vol.111, p.1133, 2003.

G. B. Elion, The George Hitchings and Gertrude Elion Lecture. The pharmacology of azathioprine, Ann N Y Acad Sci, vol.685, p.400, 1993.

N. Poirier, G. Blancho, and B. Vanhove, Alternatives to calcineurin inhibition in renal transplantation: belatacept, the first co-stimulation blocker, Immunotherapy, vol.2, p.625, 2010.

N. Poirier, G. Blancho, and B. Vanhove, A more selective costimulatory blockade of the CD28-B7 pathway, Transpl Int, vol.24, issue.2, 2011.

N. Pilat and T. Wekerle, Belatacept and Tregs: friends or foes?, Immunotherapy, vol.4, p.351, 2012.

D. Abramowicz, D. Carmen, R. M. Vitko, and S. , Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study, J Am Soc Nephrol, vol.16, p.2234, 2005.

H. Ekberg, H. Tedesco-silva, and A. Demirbas, Reduced exposure to calcineurin inhibitors in renal transplantation, N Engl J Med, vol.357, p.2562, 2007.

L. M. Pallardo, F. Oppenheimer, and L. Guirado, Calcineurin inhibitor reduction based on maintenance immunosuppression with mycophenolate mofetil in renal transplant patients: POP study, Transplant Proc, vol.39, p.2187, 2007.

K. Vivek, M. M. Mustafa, and E. Rodriguez, Strategies for Blymphocyte repertoire remodeling in transplantation tolerance, Immunol Res, vol.51, issue.1, 2011.

K. A. Newell and A. S. Chong, Making a B-line for transplantation tolerance, Am J Transplant, vol.11, p.420, 2011.

J. A. Bluestone, A. W. Thomson, E. M. Shevach, and H. L. Weiner, What does the future hold for cell-based tolerogenic therapy?, Nat Rev Immunol, vol.7, p.650, 2007.

C. Liu, H. Noorchashm, and J. A. Sutter, B lymphocytedirected immunotherapy promotes long-term islet allograft survival in nonhuman primates, Nat Med, vol.13, p.1295, 2007.

D. Kopchaliiska, A. A. Zachary, R. A. Montgomery, and M. S. Leffell, Reconstitution of peripheral allospecific CD19+ B-cell subsets after B-lymphocyte depletion therapy in renal transplant patients, Transplantation, vol.87, p.1394, 2009.

S. S. Kelishadi, A. M. Azimzadeh, and T. Zhang, Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys, J Clin Invest, vol.120, p.1275, 2010.

I. P. Alwayn, Y. Xu, and M. Basker, Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20-and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody, Xenotransplantation, vol.8, p.157, 2001.

T. Kozlowski and K. Andreoni, Limitations of rituximab/IVIg desensitization protocol in kidney transplantation, Ann Transplant, vol.16, p.19, 2011.

A. S. Munoz, A. A. Rioveros, C. B. Cabanayan-casasola, R. A. Danguilan, and E. T. Ona, Rituximab in highly sensitized kidney transplant recipients, Transplant Proc, vol.40, p.2218, 2008.

E. J. Ramos, H. S. Pollinger, M. D. Stegall, J. M. Gloor, A. Dogan et al., The effect of desensitization protocols on human splenic B-cell populations in vivo, Am J Transplant, vol.7, p.402, 2007.

R. F. Parsons, K. Vivek, and S. Y. Rostami, Acquisition of humoral transplantation tolerance upon de novo emergence of B lymphocytes, J Immunol, vol.186, p.614, 2011.

R. F. Parsons, R. R. Redfield, . Iii, and E. Rodriguez, Primary B cell repertoire remodeling to achieve humoral transplantation tolerance, Semin Immunol, vol.24, p.109, 2012.

X. Fan, A. Ang, and S. M. Pollock-barziv, Donor-specific Bcell tolerance after ABO-incompatible infant heart transplantation, Nat Med, vol.10, p.1227, 2004.

V. Zarkhin, L. Li, and M. M. Sarwal, BAFF may modulate the rate of B-cell repopulation after rituximab therapy for acute renal transplant rejection, Transplantation, vol.88, p.1229, 2009.

R. F. Parsons, K. Vivek, and R. R. Redfield, B-cell tolerance in transplantation: is repertoire remodeling the answer?, Expert Rev Clin Immunol, vol.5, p.703, 2009.